SPI Pharmaceuticals: The Costa Mesa drug company...
- Share via
SPI Pharmaceuticals: The Costa Mesa drug company said profit for the first quarter nearly doubled to $8.4 million, or 41 cents a share, from $5.7 million, or 29 cents a share, for the same period last year. Sales dropped 40%, however, to $72.2 million from $119.6 million. The company attributed the decline to lower sales in Yugoslavia.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
